Henry Schein (CH:HS2)
:HS2
HS2 Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Recurring Consumables DistributionHenry Schein's core distribution of consumables produces repeat ordering and sticky customer relationships, creating durable, predictable revenue and inventory turnover. That recurring demand supports steady top-line visibility, stable working capital cycles and long-term cash generation for the business.
Shift Toward Higher‑margin Services And SoftwareThe structural mix shift into cloud software, practice technology and value‑added services increases recurring, higher-margin revenue versus pure distribution. Over months to years, this reduces revenue cyclicality, improves operating leverage potential and raises long-term margin resilience if execution continues.
Defined Multi‑year Cost And Value‑creation ProgramA concrete, quantified cost and gross‑profit program provides a clear path to sustainable operating margin expansion. If delivered, these initiatives (procurement, back‑office outsourcing, pricing) can structurally lift operating income, improving cash flow conversion and flexibility over the medium term.
Bears Say
Elevated LeverageMaterial debt accumulation reduces financial flexibility and increases interest and refinancing risk. Higher leverage constrains the company's ability to fund M&A, invest in growth, or absorb shocks, making multi‑quarter execution and realization of cost savings more critical to restore balance‑sheet headroom.
Structural Margin CompressionA roughly 2‑point net‑margin erosion versus prior years means revenue gains translate to less bottom‑line improvement. Persistent margin pressure reduces free cash flow sensitivity to sales growth and limits capacity to delever or reinvest, heightening reliance on the cost program to restore long‑term profitability.
Weakened Cash Flow And Seasonal VolatilityDeclining free cash flow and seasonal operating cash flow swings (negative Q1 noted) reduce the company’s ability to rapidly pay down debt or fund transformation. Persistent cash‑flow softness would slow deleveraging, constrain strategic investments and increase sensitivity to cost or demand shocks over the medium term.
Henry Schein News
HS2 FAQ
What was Henry Schein’s price range in the past 12 months?
Currently, no data Available
What is Henry Schein’s market cap?
Henry Schein’s market cap is CHF7.29B.
When is Henry Schein’s upcoming earnings report date?
Henry Schein’s upcoming earnings report date is Aug 11, 2026 which is in 62 days.
How were Henry Schein’s earnings last quarter?
Henry Schein released its earnings results on May 05, 2026. The company reported CHF1.055 earnings per share for the quarter, beating the consensus estimate of CHF0.974 by CHF0.082.
Is Henry Schein overvalued?
According to Wall Street analysts Henry Schein’s price is currently Undervalued.
Does Henry Schein pay dividends?
Henry Schein does not currently pay dividends.
What is Henry Schein’s EPS estimate?
Henry Schein’s EPS estimate is 0.99.
How many shares outstanding does Henry Schein have?
Currently, no data Available
What happened to Henry Schein’s price movement after its last earnings report?
Henry Schein reported an EPS of CHF1.055 in its last earnings report, beating expectations of CHF0.974. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Henry Schein?
Currently, no hedge funds are holding shares in CH:HS2
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Henry Schein Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
CHF69.03 (― Downside)
CHF69.03 (― Downside)
Blogger Sentiment
Bullish
CH:HS2 Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth CHF294.1K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
9.19%
12-Months-Change
Fundamentals
Return on Equity
11.86%
Trailing 12-Months
Asset Growth
7.86%
Trailing 12-Months
Company Description
Henry Schein
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.
HS2 Company Deck
HS2 Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented multiple strong operational and financial positives — solid revenue growth (+6.3% total, 2.5% internal), non-GAAP margin expansion (+28 bps), adjusted EBITDA growth (+11.6%), cloud/customer momentum (+25% cloud subscribers), rapid e-commerce adoption (80%+ U.S. dental e-commerce), and an explicit multi-year value-creation plan with a $125 million 2026 run-rate target and a >$200 million longer-term target. Offsetting these were manageable but important risks: a Q1 GAAP margin dip and slight GAAP net income decline, negative Q1 operating cash flow (seasonal), softness in medical diagnostics due to a light flu season, digital equipment ASP pressure, restructuring costs ($12M in Q1), and exposure to rising oil/freight costs. Overall, the positives (growth, margin expansion on a non-GAAP basis, technology and e-commerce traction, and clear cost-transformation initiatives) materially outweigh the near-term headwinds and execution costs, supporting an optimistic outlook grounded with prudent caveats around macro and timing of savings.View all CH:HS2 earnings summariesHS2 Revenue Breakdown
84.48% Global Distribution and Value-Added Services
11.71% Global Specialty Products
5.12% Global Technology
-1.31% Eliminations
HS2 Stock 12 Month Forecast
Average Price Target
CHF69.03
Options Prices
Currently, No data available
---